MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MDWD MediWound

Closed Good Friday 04-17 16:00:00 EDT

17.10

+0.81

+4.97%

盘后17.10

+0.000.00%

19:04 EDT

High17.51	Low16.33	Vol138.25K
Open16.33	D1 Closing16.29	Amplitude7.24%
Mkt Cap184.81M	Tradable Cap131.71M	Total Shares10.81M
T/O2.37M	T/O Rate1.79%	Tradable Shares7.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"MDWD","market":"US","secType":"STK","nameCN":"MediWound","latestPrice":17.1,"timestamp":1744920000000,"preClose":16.29,"halted":0,"volume":138247,"hourTrading":{"tag":"盘后","latestPrice":17.1,"preClose":17.1,"latestTime":"19:04 EDT","volume":332,"amount":5677.16,"timestamp":1744931049736},"delay":0,"floatShares":7702089,"shares":10807726,"eps":-3.034622,"marketStatus":"Closed Good Friday","change":0.81,"latestTime":"04-17 16:00:00 EDT","open":16.33,"high":17.51,"low":16.33,"amount":2371366.827652,"amplitude":0.072437,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.034622,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1395288000000,"exchange":"NASDAQ","adjPreClose":16.29,"preHourTrading":{"tag":"盘前","latestPrice":15.81,"preClose":16.29,"latestTime":"04:06 EDT","volume":1,"amount":15.81,"timestamp":1744877195404},"postHourTrading":{"tag":"盘后","latestPrice":17.1,"preClose":17.1,"latestTime":"19:04 EDT","volume":332,"amount":5677.16,"timestamp":1744931049736},"volumeRatio":3.0737602928363628,"impliedVol":0.5432,"impliedVolPercentile":0.5139},"requestUrl":"/m/hq/s/MDWD","defaultTab":"news","newsList":[{"id":"2527921733","title":"Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527921733","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527921733?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 19:06","pubTimestamp":1744801560,"startTime":"0","endTime":"0","summary":"It hasn't been the best quarter for MediWound Ltd.  shareholders, since the share price has fallen 15% in that time. But the silver lining is the stock is up over five years. Unfortunately its return of 30% is below the market return of 109%.Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.  We've discovered. MediWound wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share . Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.Over the last half decade MediWound's revenue has actually been trending down at about 5.7% per year. The stock is only up 5% for each year during the period. That's pretty decent given the top line decline, and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/those-invested-mediwound-nasdaq-mdwd-110600000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BGHQF748.EUR",".IXIC","QLD","MDWD","SQQQ","IE00BKPKM429.USD","NQmain","PSQ","LU2210150020.SGD","TQQQ","IE00B3QW5Z07.USD","LU2095319765.USD","MNQmain","BK4007","LU2210149790.SGD","TSYW.SI","BK4588","NDAQ","BK4585","QID","IE00B64PRP62.GBP","BK4112","USAW.SI","NVIW.SI","USJW.SI"],"gpt_icon":1},{"id":"2525807970","title":"MediWound Announces 2025 Annual General Meeting and Key Agenda Items","url":"https://stock-news.laohu8.com/highlight/detail?id=2525807970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525807970?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 04:28","pubTimestamp":1744057706,"startTime":"0","endTime":"0","summary":"Mediwound ( ($MDWD) ) just unveiled an announcement. MediWound Ltd. has announced its 2025 Annual General Meeting of Shareholders, scheduled for Ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-2025-annual-general-meeting-and-key-agenda-items?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-2025-annual-general-meeting-and-key-agenda-items?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520437322","title":"Strategic Advancements and Market Potential Drive Buy Rating for Mediwound","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437322?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:55","pubTimestamp":1742468114,"startTime":"0","endTime":"0","summary":"Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Mediwound (MDWD – Research Report). The associated price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-market-potential-drive-buy-rating-for-mediwound?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-market-potential-drive-buy-rating-for-mediwound?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2520432380","title":"Loss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2520432380","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520432380?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:37","pubTimestamp":1742467067,"startTime":"0","endTime":"0","summary":"MediWound Ltd.  is possibly approaching a major achievement in its business, so we would like to shine some light on the company. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. On 31 December 2024, the US$208m market-cap company posted a loss of US$30m for its most recent financial year. The most pressing concern for investors is MediWound's path to profitability – when will it breakeven?We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.MediWound is bordering on breakeven, according to the 4 American Pharmaceuticals analysts. They anticipate the company to incur a final loss in 2026, before generating positive profits of US$236k in 2027. The company is therefore projected to breakeven around 2 years from today. In order to meet thi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/loss-making-mediwound-ltd-nasdaq-103747845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","TSYW.SI","MDWD","IE00B3QW5Z07.USD","NQmain","QID","USJW.SI","LU2210150020.SGD","MNQmain","NVIW.SI","PSQ","BK4007","LU2210149790.SGD",".IXIC","IE00BKPKM429.USD","SQQQ","BK4588","TQQQ","USAW.SI","BK4585","LU2095319765.USD","QLD","BK4112","NDAQ"],"gpt_icon":1},{"id":"2520434168","title":"MediWound Price Target Maintained With a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520434168","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520434168?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:26","pubTimestamp":1742466360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDWD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2025 06:26 ET (10:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD"],"gpt_icon":0},{"id":"2520781431","title":"Mediwound’s Promising Future: Buy Rating Backed by Clinical Advancements and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2520781431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520781431?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:16","pubTimestamp":1742465816,"startTime":"0","endTime":"0","summary":"Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Mediwound (MDWD – Research Report), retaining the price target of $25....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mediwounds-promising-future-buy-rating-backed-by-clinical-advancements-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mediwounds-promising-future-buy-rating-backed-by-clinical-advancements-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2520401106","title":"MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2520401106","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520401106?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 15:01","pubTimestamp":1742454106,"startTime":"0","endTime":"0","summary":"Q4 2024 Revenue: $5.8 million, up from $5.3 million in Q4 2023.Q4 2024 Gross Profit: $0.9 million with a gross margin of 15.5%, up from $0.7 million and a 13.5% margin in Q4 2023.Q4 2024 R&D Expenses: $3 million, compared to $1.8 million in Q4 2023.Q4 2024 SG&A Expenses: $4 million, compared to $2.8 million in Q4 2023.Q4 2024 Operating Loss: $6.1 million, compared to $3.9 million in Q4 2023.Q4 2024 Net Loss: $3.9 million or $0.36 per share, compared to $1.7 million or $0.19 per share in Q4 2023.Q4 2024 Adjusted EBITDA Loss: $4.9 million, compared to $3.2 million in Q4 2023.Full Year 2024 R&D Expenses: $8.9 million, compared to $7.5 million in 2023.Full Year 2024 SG&A Expenses: $13.1 million, compared to $11.6 million in 2023.Full Year 2024 Operating Loss: $19.4 million, compared to $15.3 million in 2023.Full Year 2024 Net Loss: $30.2 million or $3.03 per share, compared to $6.7 million or $0.75 per share in 2023.Full Year 2024 Adjusted EBITDA Loss: $14.8 million, compared to $12.3 mill","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mediwound-ltd-mdwd-q4-2024-070146161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDWD"],"gpt_icon":0},{"id":"2520091122","title":"MediWound Reports 2024 Financials and Strategic Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2520091122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520091122?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 11:54","pubTimestamp":1742442849,"startTime":"0","endTime":"0","summary":"Mediwound ( ($MDWD) ) has released its Q4 earnings. Here is a breakdown of the information Mediwound presented to its investors. MediWound Ltd., a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwound-reports-2024-financials-and-strategic-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwound-reports-2024-financials-and-strategic-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520199543","title":"MediWound Files for $125 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199543","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199543?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 04:54","pubTimestamp":1742417648,"startTime":"0","endTime":"0","summary":"MediWound (MDWD) filed a registration statement with the US Securities and Exchange Commission on Wednesday for the sale of $125 million in securities.Additionally, selling shareholders may offer up t","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520195391","title":"MediWound files $125M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2520195391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520195391?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 04:11","pubTimestamp":1742415095,"startTime":"0","endTime":"0","summary":"16:08 EDT MediWound (MDWD) files $125M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mediwound-files-125m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mediwound-files-125m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520953141","title":"MediWound files to sell 1.26M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2520953141","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520953141?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 04:11","pubTimestamp":1742415071,"startTime":"0","endTime":"0","summary":"The company will not receive any of the proceeds from the sale of ordinary shares by the selling shareholder. Published first on TheFly – the ultim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mediwound-files-to-sell-1-26m-ordinary-shares-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mediwound-files-to-sell-1-26m-ordinary-shares-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MDWD"],"gpt_icon":0},{"id":"2520821971","title":"Wall Street Awaits Fed Rate Decision as US Equity Futures Waver Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2520821971","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520821971?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:01","pubTimestamp":1742389299,"startTime":"0","endTime":"0","summary":"US equity futures were little changed ahead of Wednesday's opening bell as investors awaited the Federal Reserve's interest rate decision.The Dow Jones Industrial Average futures were flat, S&P 500 fu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DJX","ADSK","USJW.SI","LU0345774391.USD","SQQQ","US2Y.BOND","LU0323240290.USD","MDWD",".SPX","TQQQ","SDOW","IE00BZ9MQY76.HKD","BK4554","EQR","HQY","TSYW.SI","MNQmain","LU2065731478.USD","NVIW.SI","LU0323239441.USD","US10Y.BOND","BK4588","NQmain","DOG","DXD","QID","US7Y.BOND","LU1235294995.USD","US12M.BOND","US30Y.BOND","QLD","LU1823568750.SGD",".DJI","USAW.SI","US5Y.BOND",".IXIC","DDM","US3Y.BOND","BK4534","LU2238339852.HKD","LU1983260115.SGD","LU2125910179.SGD","US6M.BOND","LU0426412945.USD","PSQ","UDOW","BK4023","LU0426417589.USD","LU1939255532.USD"],"gpt_icon":1},{"id":"2520904007","title":"MediWound: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2520904007","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520904007?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:17","pubTimestamp":1742383029,"startTime":"0","endTime":"0","summary":"YAVNE, Israel  — YAVNE, Israel  — MediWound Ltd.  on Wednesday reported a loss of $3.9 million in its fourth quarter.The Yavne, Israel-based company said it had a loss of 36 cents per share.The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.The developer of treatments for burns and hard-to-heal wounds posted revenue of $5.8 million in the period, which matched Street forecasts.For the year, the company reported a loss of $30.2 million, or $3.03 per share. Revenue was reported as $20.2 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mediwound-q4-earnings-snapshot-111709374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDWD"],"gpt_icon":0},{"id":"2520909719","title":"MediWound Q4 2024 GAAP EPS $(0.36) Beats $(0.59) Estimate, Sales $5.84M Beat $5.75M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520909719","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520909719?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:01","pubTimestamp":1742382107,"startTime":"0","endTime":"0","summary":"MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.59) by 38.98 percent. This is a 89.47 percent decrease over losses of $(0.19) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44394133/mediwound-q4-2024-gaap-eps-0-36-beats-0-59-estimate-sales-5-84m-beat-5-75m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MediWound Q4 2024 GAAP EPS $(0.36) Beats $(0.59) Estimate, Sales $5.84M Beat $5.75M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD"],"gpt_icon":0},{"id":"2520909257","title":"Mediwound Q4 Adjusted Ebitda USD -4.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520909257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520909257?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nPLX363DAE:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520909237","title":"Mediwound Q4 Revenue USD 5.8 Million VS. Ibes Estimate USD 5.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520909237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520909237?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nPLX363DAE:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MDWD"],"gpt_icon":0},{"id":"2520790924","title":"Mediwound Q4 Gross Profit USD 900 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2520790924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520790924?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nPLX363DAE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520909211","title":"Mediwound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520909211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520909211?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUABWJ83Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2520904013","title":"MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520904013","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520904013?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382000,"startTime":"0","endTime":"0","summary":"Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for 2024; $24 million projected for 2025; $44 million in cash as of Year-End 2024. Conference call today, March 19 at 8:30am Eastern Time. YAVNE, Israel, March 19, 2025  -- MediWound Ltd. , a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a corporate update.“2024 was a pivotal year for MediWound, marked by strong execution, clinical progress, and strategic collaborations,” said Ofer Gonen, CEO of MediWound. “The initiation of the VALUE Phase III pivotal study is another major milestone, further reinforced by partnerships with industry leaders that highlight EscharEx’s clinical and commercial potential. At the same time, the global adoption of NexoBrid continues to accelerate, solidifying its critical role in modern burn care. With our innovat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mediwound-reports-fourth-quarter-full-110000496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBSA","NEXT","EIC","MDWD","BK4144","BK4007"],"gpt_icon":0},{"id":"2520523267","title":"Mediwound Ltd  expected to post a loss of 61 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520523267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520523267?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 20:35","pubTimestamp":1742214907,"startTime":"0","endTime":"0","summary":"Mediwound Ltd  expected to post a loss of61cents a share - Earnings Preview Mediwound Ltd MDWD.OQ MDWD.O is expected to show a rise in quarterly revenue when it reports  results on March 19 for the pe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q00X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mediwound.com","stockEarnings":[{"period":"1week","weight":0.1362},{"period":"1month","weight":-0.1126},{"period":"3month","weight":-0.0306},{"period":"6month","weight":-0.0273},{"period":"1year","weight":-0.0195},{"period":"ytd","weight":-0.0393}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.114505},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.013432},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.01746},{"month":4,"riseRate":0.583333,"avgChangeRate":0.003039},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.035305},{"month":6,"riseRate":0.545455,"avgChangeRate":0.059921},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.021922},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.014559},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.025217},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.059831},{"month":11,"riseRate":0.545455,"avgChangeRate":0.014709},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.023016}],"exchange":"NASDAQ","name":"MediWound","nameEN":"MediWound"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MediWound(MDWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MediWound,MDWD,MediWound股票,MediWound股票老虎,MediWound股票老虎国际,MediWound行情,MediWound股票行情,MediWound股价,MediWound股市,MediWound股票价格,MediWound股票交易,MediWound股票购买,MediWound股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MediWound(MDWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction